Kymera Therapeutics (KYMR) EBIT Margin (QoQ) (2019 - 2026)
Kymera Therapeutics (KYMR) EBIT Margin (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Kymera Therapeutics |
8.84 Bn |
8.19 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
316,613.00 |
| Dec 31, 2025 |
-6,365.00 |
| Sep 30, 2025 |
-261,054.00 |
| Jun 30, 2025 |
-40,005.00 |
| Mar 31, 2025 |
75,540.00 |
| Dec 31, 2024 |
83,576.00 |
| Sep 30, 2024 |
-172,940.00 |
| Jun 30, 2024 |
36,364.00 |
| Mar 31, 2024 |
-52,185.00 |
| Dec 31, 2023 |
117,602.00 |
| Sep 30, 2023 |
-95,363.00 |
| Jun 30, 2023 |
21,611.00 |
| Mar 31, 2023 |
-23,947.00 |
| Dec 31, 2022 |
23,056.00 |
| Sep 30, 2022 |
-11,548.00 |
| Jun 30, 2022 |
2,940.00 |
| Mar 31, 2022 |
-16,129.00 |
| Dec 31, 2021 |
-8,173.00 |
| Sep 30, 2021 |
-728.00 |
| Jun 30, 2021 |
-6,312.00 |
